OCTOBER - 20225TECH OUTLOOKAnalytical Considerations for Combination ProductsIN MY OPINIONJennifer Riter, Sr. Director, Analytical Services, West Pharmaceutical Services, Inc.08LAST WORDThe Ever-Evolving Challenges in Drug Development and ManufacturingWhy Strain Typing Should be in Your Microbial Control ToolboxKimberly Paris,SVP & Chief Compliance Officer,Quotient SciencesJon Kallay,Senior Technology and Market Development Manager,Charles River Laboratories2225Data Science in R&D: It Is about Culture!Philippe Marc, Executive Director, Global Head of Integrated Data Science, Novartis30Overcoming Global Drug Safety Operations and Safety Reporting ChallengesThe Value of Technology in PharmacovigilanceSteven Beales,Senior Vice President,Safety Reporting,WCGAnnette Stemhagen,Senior Vice President,UBC2827C O N TE N TS
< Page 4 | Page 6 >